All Articles

Beyond impressive headline numbers, Auburn National's Q2 results reveal a masterclass in strategic execution, from technical accounting shifts to capitalizing on regional growth.

Firefly's AI brain mapping joins Next Health's peptide therapies, spurred by a key FDA panel vote. Is this the future of cognitive care or a risky leap?

A new report reveals a stark paradox: while AI writes code faster than ever, its ability to write secure code has stalled, creating a massive hidden risk.

NJ launches a statewide therapy program to keep families together, pioneering a model for preventative child welfare built on data and partnership.

A California initiative is betting it can fix employer healthcare by wiring a nonprofit mission into the system's administrative core. Is this the future?

Lantern Pharma's EMA-cleared trial for LP-184 uses a dual-biomarker strategy, targeting a multi-billion dollar market where patient options are scarce.

Cleveland's Changing Lives Foundation hosts 'An Evening of Impact' to fund its mission of providing immediate, crucial aid to families facing sudden catastrophe.

S&P Global acquires datacenterHawk, signaling a strategic push to map the physical world of AI. The deal highlights the soaring value of data center intelligence.

Without a dime of VC funding, a nurse-owned telepsychiatry practice hit 300k appointments, proving a clinician-first model can thrive.

A new acquisition merges veterinary science with vision-AI, creating a 'digital twin' for pets that analyzes behavior to offer proactive nutritional care.

How one firm's rare feat of achieving both zero injuries and top workplace status for the seventh time offers a powerful lesson in strategic value.

Marion Munley's elevation to AAJ President-Elect isn't just a career milestone; it's a strategic maneuver signaling a more aggressive, specialized fight ahead.

The travel club's Q2 results reveal deep losses and cash burn from its new membership model, testing investor faith amidst geopolitical headwinds.

Korg USA's partnership with Long Island Cares reveals a shift in corporate giving, where hands-on action and leadership are the new keys to success.

A landmark FDA approval allows Walter Reed to 3D-print cranial implants on-site, a strategic shift in military medicine powered by 3D Systems' expertise.

As Riot Platforms preps its Q2 earnings call, the real story isn't just Bitcoin. It's a strategic pivot to building the massive infrastructure for our digital future.

As NAVs fall, Cox Capital expands its discounted tender offers for non-traded BDCs, creating a crucial exit for investors and reshaping the private credit landscape.

A new biotech, CORE Biomedicine, armed with Eisai's preclinical assets and a $21M Series A, aims to upend oncology by targeting cancer's 'lineage' identity.